At a glance
ClinicalIndex Comparison RecordN/ACompleted· 618 enrolled
Drug / intervention
nephrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Provider Referral Patterns Following Nephrectomy in High-Risk Locoregional Renal Cell Carcinoma
In Brief
An observational study evaluating nephrectomy for Renal Cell Carcinoma. Completed, enrolled 618 participants across 1 site.
Detailed Summary
This study aims at estimating the proportion of patients diagnosed with locoregional renal cell carcinoma who are at high risk for recurrence following nephrectomy, describe referral patterns, and characterize treatment in this population. Outcomes including estimation of the incidence of recurrence and disease-free interval following nephrectomy will be reported overall and among the subgroup off patients receiving adjuvant systemic therapy with sunitinib following nephrectomy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Cell Carcinoma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJul 2019
First PostedMar 2020
Primary CompletionApr 2020
TodayJul 2026
First PostedMar 16, 2020
Enrollment StartJul 31, 2019
Primary CompletionApr 28, 2020
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 6.3 years ago
Interventions
nephrectomyprocedure
Surgery performed within the study period